SEC Form 4 · accession 0001144204-16-074054
Fortress Biotech, Inc. · FBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dov Klein
Director
Period of report
Jan 1, 2016
Accepted (ET)
Jan 5, 2016 · 4:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001429260
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001F1 | Jan 1, 2016 | A | 100,000 | $0.00 | A | 155,000 | D | |
| Common Stock, par value $0.001 | holding | — | — | — | 1,800 | I | By Wife |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1One-third of the shares will vest on each of January 1, 2017, 2018 and 2019, and subject to continued service on the board of directors.